Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Explore a variety of travel cards that charge no annual fees. Save on costs while maximizing your travel rewards.
26,784 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Marvell Technology has surged in 2026 as AI infrastructure demand accelerates. Here is a timely look at the case for ...
A veteran SpaceX backer contends the $2 trillion IPO valuation understates the long-term growth in space infrastructu...
A downtown Pittsburgh convenience store is at the center of allegations that SNAP benefits were converted to cash and...
Apple sticks to an asset-light model with robust buybacks, while Microsoft escalates capital spending to fuel AI and ...
AI is reshaping professional services by speeding up tasks and boosting ROI. This report highlights how AI is impacti...
Robinhood Chain goes live on mainnet, delivering Layer 2 scalability for tokenized assets and a suite of around-the-c...
France faces a sharp rise in crypto related abductions, forcing authorities to trace the personal data criminals expl...
An investor explains a dip‑buying method focused on Nvidia, detailing how long‑term AI demand and enterprise commitme...
Lenders moved 266 loan originators and issued 1,823 NMLS licenses in RETR's latest market intelligence, underscoring ...
Micron posts strong AI-driven memory demand and rising cloud bookings, while Apple relies on devices and services to ...